Research ArticleOriginal Article
Open Access

Human papillomavirus prevalence and dynamics

Insights from a 5-year population-based study in Jeddah, Kingdom of Saudi Arabia

Khalid H. Sait, Nisreen M. Anfinan, Hesham K. Sait and Hussain A. Basalamah
Saudi Medical Journal March 2024, 45 (3) 252-260; DOI: https://doi.org/10.15537/smj.2024.45.3.20230824

References

  1. 1.↵
    1. Pal A,
    2. Kundu R.
    Human papillomavirus E6 and E7: the cervical cancer hallmarks and targets for therapy. Front Microbiol 2020; 10: 3116.
    OpenUrl
  2. 2.↵
    World Health Organization. Cervical cancer (Updated 2023; Cited date 2023 Nov 17). Available from: https://www.who.int/news-room/fact-sheets/detail/cervical-cancer
  3. 3.↵
    1. de Martel C,
    2. Georges D,
    3. Bray F,
    4. Ferlay J,
    5. Clifford GM.
    Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis. Lancet Glob Health 2020; 8: e180-e190.
    OpenUrlPubMed
  4. 4.↵
    Centers for Disease Control and Prevention. Cancers associated with human papillomavirus. (Updated 2023; Cited date 2023 Feb 04). Available from: https://www.cdc.gov/cancer/hpv/basic_info/cancers.htm
  5. 5.↵
    1. Huang J,
    2. Deng Y,
    3. Boakye D,
    4. Tin MS,
    5. Lok V,
    6. Zang L, et al.
    Global distribution, risk factors, and recent trends for cervical cancer: A worldwide country-level analysis. Gynecol Oncol 2022; 164: 85-92.
    OpenUrl
  6. 6.↵
    1. AlObaid A,
    2. Al-Badawi IA,
    3. Al-Kadri H,
    4. Gopala K,
    5. Kandeil W,
    6. Quint W, et al.
    Human papillomavirus prevalence and type distribution among women attending routine gynecological examinations in Saudi Arabia. BMC Infect Dis 2014; 14: 643.
    OpenUrl
  7. 7.↵
    1. Turki R,
    2. Sait K,
    3. Anfinan N,
    4. Sohrab SS,
    5. Abuzenadah AM.
    Prevalence of human papillomavirus in women from Saudi Arabia. Asian Pac J Cancer Prev 2013; 14: 3177-3181.
    OpenUrl
  8. 8.↵
    1. Mousa M,
    2. Al-Amri SS,
    3. Degnah AA,
    4. Tolah AM,
    5. Abduljabbar HH,
    6. Oraif AM, et al.
    Prevalence of human papillomavirus in Jeddah, Saudi Arabia. Ann Saudi Med 2019; 39: 403-409.
    OpenUrl
  9. 9.↵
    ICO/IARC Information Centre on HPV and Cancer. Saudi Arabia - Human papillomavirus and related cancers, fact sheet 2021. [Updated 2023 Mar 10; Cited 2023 Aug 26]. Available at: https://hpvcentre.net/statistics/reports/SAU_FS.pdf
  10. 10.↵
    1. Al-Mandeel HM,
    2. Sagr E,
    3. Sait K,
    4. Latifah HM,
    5. Al-Obaid A,
    6. Al-Badawi IA, et al.
    Clinical practice guidelines on the screening and treatment of precancerous lesions for cervical cancer prevention in Saudi Arabia. Ann Saudi Med 2016; 36: 313-320.
    OpenUrl
  11. 11.↵
    1. Brisson M,
    2. Kim JJ,
    3. Canfell K,
    4. Drolet M,
    5. Gingras G,
    6. Burger EA, et al.
    Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries. Lancet 2020; 395: 575-590.
    OpenUrlCrossRefPubMed
  12. 12.↵
    1. Eun TJ,
    2. Perkins RB.
    Screening for cervical cancer. Med Clin North Am 2020; 104: 1063-1078.
    OpenUrl
  13. 13.↵
    1. Anfinan N,
    2. Sait K.
    Indicators of survival and prognostic factors in women treated for cervical cancer at a tertiary care center in Saudi Arabia. Ann Saudi Med 2020; 40: 25-35.
    OpenUrl
  14. 14.↵
    1. Sait K,
    2. Bentley J,
    3. Anfinan N,
    4. Power P.
    Cervical cancer prevention in Saudi Arabia: It is time to call for action. The Open Women’s Health Journal 2012; 6: 1-5.
    OpenUrl
  15. 15.↵
    1. Sankaranarayanan R,
    2. Basu P,
    3. Wesley RS,
    4. Mahe C,
    5. Keita N,
    6. Mbalawa CCG, et al.
    Accuracy of visual screening for cervical neoplasia: Results from an IARC multicentre study in India and Africa. Int J Cancer 2004; 110: 907-913.
    OpenUrlCrossRefPubMedWeb of Science
  16. 16.↵
    1. Hirth J.
    Disparities in HPV vaccination rates and HPV prevalence in the United States: a review of the literature. Hum Vaccin Immunother 2019; 15: 146-155.
    OpenUrlCrossRef
  17. 17.↵
    1. Itarat Y,
    2. Kietpeerakool C,
    3. Jampathong N,
    4. Chumworathayi B,
    5. Kleebkaow P,
    6. Aue-Aungkul A, et al.
    Sexual behavior and infection with cervical human papillomavirus types 16 and 18. Int J Womens Health 2019; 11: 489-494.
    OpenUrl
  18. 18.↵
    1. Pimple S,
    2. Mishra G.
    Cancer cervix: Epidemiology and disease burden. Cytojournal 2022; 19: 21.
    OpenUrl
  19. 19.↵
    1. Huber J,
    2. Mueller A,
    3. Sailer M,
    4. Regidor PA.
    Human papillomavirus persistence or clearance after infection in reproductive age. What is the status? Review of the literature and new data of a vaginal gel containing silicate dioxide, citric acid, and selenite. Womens Health (Lond) 2021; 17: 17455065211020702.
    OpenUrl
  20. 20.↵
    1. Krings A,
    2. Boateng G,
    3. Dunyo P,
    4. Amuah J,
    5. Adams R,
    6. Adunyame L, et al.
    Dynamics of genotype-specific HPV clearance and reinfection in rural Ghana may compromise HPV screening approaches. Papillomavirus Res 2019: 7: 45-51.
    OpenUrl
  21. 21.↵
    1. Tekalegn Y,
    2. Sahiledengle B,
    3. Woldeyohannes D,
    4. Atlaw D,
    5. Degno S,
    6. Desta F et al.
    High parity is associated with increased risk of cervical cancer: Systematic review and meta-analysis of case-control studies. Womens Health (Lond) 2022; 18: 17455065221075904.
    OpenUrl
  22. 22.↵
    1. Anastasiou E,
    2. McCarthy KJ,
    3. Gollub EL,
    4. Ralph L,
    5. van de Wijgert JHHM,
    6. Jones HE.
    The relationship between hormonal contraception and cervical dysplasia/cancer controlling for human papillomavirus infection: A systematic review. Contraception 2022; 107: 1-9.
    OpenUrl
  23. 23.↵
    1. Duong LM,
    2. Pham LV,
    3. Pham TT,
    4. Tran DN,
    5. Bui NQ,
    6. Tran H Do, et al.
    DNA-HPV transition rate and related factors in HPV-infected women in Can Tho city, Vietnam. Trop Med Int Health 2019; 24: 1330-1334.
    OpenUrl
  24. 24.↵
    1. Obaid ZM,
    2. Amer AW,
    3. Zaky MS,
    4. Elhenawy RM,
    5. Megahed AEM,
    6. Hanafy NS, et al.
    Prevalence of female sexual dysfunction among diabetic females: a cross- sectional case controlled study. Postgrad Med 2022; 134: 680-685.
    OpenUrl
  25. 25.↵
    1. Gul R,
    2. Gul S,
    3. Khan MA,
    4. Satti RRUH.
    Sexual dysfunction: Prevalence and relationship with depression and other socio-demographic factors among the type 2 diabetic women of Pakistan. J Pak Med Assoc 2021; 71: 2515-2518.
    OpenUrl
  26. 26.↵
    1. Santana LM,
    2. Perin L,
    3. Lunelli R,
    4. Inácio JFS,
    5. Rodrigues CG,
    6. Eibel B, et al.
    Sexual dysfunction in women with hypertension: a systematic review and meta-analysis. Curr Hypertens Rep 2019; 21: 25.
    OpenUrl
  27. 27.↵
    1. Murfin J,
    2. Irvine F,
    3. Meechan-Rogers R,
    4. Swift A. Education
    , income and occupation and their influence on the uptake of cervical cancer prevention strategies: A systematic review. J Clin Nurs 2020; 29: 393-415.
    OpenUrlCrossRefPubMed
  28. 28.↵
    1. Pauli S,
    2. Kops NL,
    3. Bessel M,
    4. Lina Villa L,
    5. Moreno Alves Souza F,
    6. Mendes Pereira GF, et al.
    Sexual practices and HPV infection in unvaccinated young adults. Sci Rep 2022; 12: 12385.
    OpenUrl
  29. 29.↵
    1. Nielsen NM,
    2. Davidsen RB,
    3. Hviid A,
    4. Wohlfahrt J.
    Divorce and risk of hospital-diagnosed infectious diseases. Scand J Public Health 2014; 42: 705–711.
    OpenUrlCrossRefPubMed
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools
Bookmark this article

Jump to section

Keywords